Hyogo, Japan

Kohki Endo

This inventor holds 1 USPTO granted patent. Top assignees: Ehime University, Fujifilm Wako Pure Chemical Corporation, Osaka University. Active years: 2021.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kohki Endo: Innovator in Antibody Development

Introduction

Kohki Endo is a prominent inventor based in Hyogo, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on creating novel molecules that exhibit high specificity to specific proteins, which can have profound implications in medical treatments.

Latest Patents

Kohki Endo holds a patent for an "Anti-CLDN-5 antibody, and drug containing said antibody." The objective of this invention is to provide a novel molecule that has high specificity to CLDN-5 and recognizes an extracellular domain of this protein. The invention is achieved through an antibody that specifically recognizes either a three-dimensional structure or a primary structure of the extracellular domain of the Claudin-5 protein.

Career Highlights

Throughout his career, Kohki Endo has worked with esteemed institutions such as Osaka University and Ehime University. His research has contributed to advancements in understanding and targeting specific proteins, which is crucial for developing effective therapies.

Collaborations

Kohki Endo has collaborated with notable individuals in his field, including Masuo Kondoh and Kiyohito Yagi. These collaborations have further enriched his research and innovation efforts.

Conclusion

Kohki Endo's work in antibody development exemplifies the importance of innovation in biotechnology. His contributions are paving the way for new therapeutic approaches that could significantly impact healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…